La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment recall
FDA recall D-0417-2025 · initiated Mar 5, 2025
L'Oreal USA recalled La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatmen… in Mar 2025 — an FDA Class II recall (D-0417-2025) because Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.
Something got into the product
A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 2,226,801 bottles
Details
- Product
- La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL. OZ.) Tube per carton, La Roche-Posay LLC, 10 Hudson Yards, New York, NY 10001, La Roche-Posay, Laboratoire Dermatologique, CAI 86270, La Roche-Posay, France, UPC 883140500759.
- Recalling company
- L'Oreal USA
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide in the USA
- Initiated
- Mar 5, 2025
- FDA report date
- May 21, 2025
Frequently asked
- Was La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatmen… recalled?
- L'Oreal USA recalled La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatmen… in Mar 2025 — an FDA Class II recall (D-0417-2025) because Chemical Contamination: This recall has been initiated due to detected trace levels of benzene. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatmen… recalled?
- Per the FDA enforcement record, the reason for recall D-0417-2025 was: Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.
- Is a recalled La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatmen… dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatmen… are affected?
- Distributed: Nationwide in the USA. The recall covers these lots — Lot #: MYX46W, Exp 04/30/2025. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0417-2025.